Who Can Represent Patients? Advocates Worry They Are Being Pushed Out Of The Conversation

Patient advocacy groups suggest US state and federal agencies are trying to exclude them from certain conversations due to drug industry connections and perceived bias.

person up front sad to be left out of larger group gathering in background — Some patient advocates worry they are being excluded from some drug pricing conversations. • Source: Shutterstock

Patient advocacy group leaders are raising concerns about what they characterize as recent attempts by government entities to limit who can publicly represent the patient perspective in discussions about drug costs.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

Start your 7-day free trial
Explore trusted news, analysis, and insights
Access comprehensive global coverage
Enjoy instant access – no credit card required

Start Free Trial

Already a subscriber?

Who Can Represent Patients? Advocates Worry They Are Being Pushed Out Of The Conversation

Read the full article – start your free trial today!

More from Pricing Debate

More from Conferences